Osteopontin is a myosphere-derived secretory molecule that promotes angiogenic progenitor cell proliferation through the phosphoinositide 3-kinase/Akt pathway

Biochemical and Biophysical Research Communications

Volumn 359, Issue 2, 2007, Pages 341-347

  Ogata, Takehiro ^a   Ueyama, Tomomi ^a   Nomura, Tetsuya ^a,b   Asada, Satoshi ^a,b   Tagawa, Masashi ^a,b   Nakamura, Tomoyuki ^c   Takahashi, Tomosaburo ^a,b   Matsubara, Hiroaki ^a,b   Oh, Hidemasa ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Differentiation; Osteopontin; Progenitor cells; Proliferation; Skeletal muscle

Indexed keywords

OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RNA; SIGNAL PEPTIDE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; SMOOTH MUSCLE FIBER; STEM CELL; VASCULAR SMOOTH MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRONECTINS; GENE EXPRESSION REGULATION; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOPONTIN; PROTO-ONCOGENE PROTEINS C-AKT; RNA;

EID: 34249942727     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.05.104     Document Type: Article

References (33)

1. Qu-Petersen Z., Deasy B., Jankowski R., Ikezawa M., Cummins J., Pruchnic R., Mytinger J., Cao B., Gates C., Wernig A., and Huard J. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J. Cell Biol. 157 (2002) 851-864
2. Oshima H., Payne T.R., Urish K.L., Sakai T., Ling Y., Gharaibeh B., Tobita K., Keller B.B., Cummins J.H., and Huard J. Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol. Ther. 12 (2005) 1130-1141
3. Payne T.R., Oshima H., Sakai T., Ling Y., Gharaibeh B., Cummins J., and Huard J. Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells. Gene Ther. 12 (2005) 1264-1274
4. Tamaki T., Akatsuka A., Ando K., Nakamura Y., Matsuzawa H., Hotta T., Roy R.R., and Edgerton V.R. Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J. Cell Biol. 157 (2002) 571-577
5. Sarig R., Baruchi Z., Fuchs O., Nudel U., and Yaffe D. Regeneration and transdifferentiation potential of muscle-derived stem cells propagated as myospheres. Stem Cells 24 (2006) 1769-1778
6. Nomura T., Ashihara E., Tateishi K., Asada S., Ueyama T., Takahashi T., Matsubara H., and Oh H. Skeletal myosphere-derived progenitor cell transplantation promotes neovascularization in δ-sarcoglycan knockdown cardiomyopathy. Biochem. Biophys. Res. Commun. 352 (2007) 668-674
7. Taupin P., Ray J., Fischer W.H., Suhr S.T., Hakansson K., Grubb A., and Gage F.H. FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor. Neuron 28 (2000) 385-397
8. Arsenijevic Y., Weiss S., Schneider B., and Aebischer P. Insulin-like growth factor-I is necessary for neural stem cell proliferation and demonstrates distinct actions of epidermal growth factor and fibroblast growth factor-2. J. Neurosci. 21 (2001) 7194-7202
9. Toda H., Tsuji M., Nakano I., Kobuke K., Hayashi T., Kasahara H., Takahashi J., Mizoguchi A., Houtani T., Sugimoto T., Hashimoto N., Palmer T.D., Honjo T., and Tashiro K. Stem cell-derived neural stem/progenitor cell supporting factor is an autocrine/paracrine survival factor for adult neural stem/progenitor cells. J. Biol. Chem. 278 (2003) 35491-35500
10. Nakamura T., Ruiz-Lozano P., Lindner V., Yabe D., Taniwaki M., Furukawa Y., Kobuke K., Tashiro K., Lu Z., Andon N.L., Schaub R., Matsumori A., Sasayama S., Chien K.R., and Honjo T. DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries. J. Biol. Chem. 274 (1999) 22476-22483
11. Kojima T., and Kitamura T. A signal sequence trap based on a constitutively active cytokine receptor. Nat. Biotechnol. 17 (1999) 487-490
12. Velculescu V.E., Vogelstein B., and Kinzler K.W. Analysing uncharted transcriptomes with SAGE. Trends Genet. 16 (2000) 423-425
13. Rodan S.B., Wesolowski G., Yoon K., and Rodan G.A. Opposing effects of fibroblast growth factor and pertussis toxin on alkaline phosphatase, osteopontin, osteocalcin, and type I collagen mRNA levels in ROS 17/2.8 cells. J. Biol. Chem. 264 (1989) 19934-19941
14. Rangaswami H., Bulbule A., and Kundu G.C. Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol. 16 (2006) 79-87
15. Tateishi K., Ashihara E., Honsho S., Takehara N., Nomura T., Takahashi T., Ueyama T., Yamagishi M., Yaku H., Matsubara H., and Oh H. Human cardiac stem cells exhibit mesenchymal features and are maintained through Akt/GSK-3β signaling. Biochem. Biophys. Res. Commun. 352 (2007) 635-641
16. Haylock D.N., and Nilsson S.K. Osteopontin: a bridge between bone and blood. Br. J. Haematol. 134 (2006) 467-474
17. Temple S., and Alvarez-Buylla A. Stem cells in the adult mammalian central nervous system. Curr. Opin. Neurobiol. 9 (1999) 135-141
18. Gritti A., Parati E.A., Cova L., Frolichsthal P., Galli R., Wanke E., Faravelli L., Morassutti D.J., Roisen F., Nickel D.D., and Vescovi A.L. Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor. J. Neurosci. 16 (1996) 1091-1100
19. Reynolds B.A., and Weiss S. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev. Biol. 175 (1996) 1-13
20. Messina E., De Angelis L., Frati G., Morrone S., Chimenti S., Fiordaliso F., Salio M., Battaglia M., Latronico M.V., Coletta M., Vivarelli E., Frati L., Cossu G., and Giacomello A. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 95 (2004) 911-921
21. Lin Y.H., and Yang-Yen H.F. The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway. J. Biol. Chem. 276 (2001) 46024-46030
22. Das R., Mahabeleshwar G.H., and Kundu G.C. Osteopontin stimulates cell motility and nuclear factor κB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells. J. Biol. Chem. 278 (2003) 28593-28606
23. Katagiri Y.U., Sleeman J., Fujii H., Herrlich P., Hotta H., Tanaka K., Chikuma S., Yagita H., Okumura K., Murakami M., Saiki I., Chambers A.F., and Uede T. CD44 variants but not CD44s cooperate with β1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res. 59 (1999) 219-226
24. Crawford H.C., Matrisian L.M., and Liaw L. Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo. Cancer Res. 58 (1998) 5206-5215
25. Wu Y., Denhardt D.T., and Rittling S.R. Osteopontin is required for full expression of the transformed phenotype by the ras oncogene. Br. J. Cancer 83 (2000) 156-163
26. Rittling S.R., and Chambers A.F. Role of osteopontin in tumour progression. Br. J. Cancer 90 (2004) 1877-1881
27. Denhardt D. Osteopontin expression correlates with melanoma invasion. J. Invest. Dermatol. 124 (2005) xvi-xviii
28. Hirata A., Masuda S., Tamura T., Kai K., Ojima K., Fukase A., Motoyoshi K., Kamakura K., Miyagoe-Suzuki Y., and Takeda S. Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontin. Am. J. Pathol. 163 (2003) 203-215
29. Asou Y., Rittling S.R., Yoshitake H., Tsuji K., Shinomiya K., Nifuji A., Denhardt D.T., and Noda M. Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone. Endocrinology 142 (2001) 1325-1332
30. Nilsson S.K., Johnston H.M., Whitty G.A., Williams B., Webb R.J., Denhardt D.T., Bertoncello I., Bendall L.J., Simmons P.J., and Haylock D.N. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 106 (2005) 1232-1239
31. Stier S., Ko Y., Forkert R., Lutz C., Neuhaus T., Grunewald E., Cheng T., Dombkowski D., Calvi L.M., Rittling S.R., and Scadden D.T. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J. Exp. Med. 201 (2005) 1781-1791
32. Simmons P.J., Levesque J.P., and Zannettino A.C. Adhesion molecules in haemopoiesis. Baillieres Clin. Haematol. 10 (1997) 485-505
33. Denhardt D.T., and Guo X. Osteopontin: a protein with diverse functions. FASEB J. 7 (1993) 1475-1482